Andrea Tan
Stock Analyst at Goldman Sachs
(0.96)
# 3,867
Out of 5,005 analysts
47
Total ratings
37.84%
Success rate
-11.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $121 → $196 | $157.16 | +24.71% | 12 | Oct 3, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $2.34 | +241.88% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $65.17 | -21.74% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $7.95 | +239.62% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $7.29 | -17.70% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $36.12 | -14.17% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $2.32 | -13.79% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $15.06 | -86.72% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $183.36 | -12.74% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $5.90 | +306.78% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.21 | +230.58% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $443.01 | -15.35% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $80 | $37.46 | +113.56% | 2 | May 24, 2022 |
Insmed
Oct 3, 2025
Maintains: Buy
Price Target: $121 → $196
Current: $157.16
Upside: +24.71%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $2.34
Upside: +241.88%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $65.17
Upside: -21.74%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $7.95
Upside: +239.62%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $7.29
Upside: -17.70%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $36.12
Upside: -14.17%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $2.32
Upside: -13.79%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $15.06
Upside: -86.72%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $183.36
Upside: -12.74%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $5.90
Upside: +306.78%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.21
Upside: +230.58%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $443.01
Upside: -15.35%
May 24, 2022
Maintains: Neutral
Price Target: $120 → $80
Current: $37.46
Upside: +113.56%